Survodutide Meets Expectations in Metabolic Dysfunction-Associated Steatohepatitis
In a phase 2 trial, survodutide met it’s primary goals for liver fat content, transaminases, and fibrosis markers.
Read More
Other Stories in Health
- 5 signs of hormonal imbalance after pregnancy
- Study reveals novel therapeutic approach for excessive alcohol use
- Brazil’s Supreme Court decriminalizes possession of marijuana for personal use
- Survodutide Meets Expectations in Metabolic Dysfunction-Associated Steatohepatitis
- Apraglutide Deemed Safe and Effective for Short Bowel Syndrome With Intestinal Failure
- Family of Audrey Wallace struggles for support while daughter in palliative care
- Family of Audrey Wallace struggles for support while daughter in palliative care
- Any nurses & parents work in an office to avoid 12 hr shifts?
- Any nurses & parents work in an office to avoid 12 hr shifts?
.png)
